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ABSTRACT 
In the context of the dangerous phenomenon of antimicrobial resistance to the available drugs, we present here the chemical synthesis and 
evaluation of a new phenoxy benzoyl methane Schiff bases (SA1-SA16), as antifungal agents. Among the compounds, SA3 was found to be most 
potent against Candida albicans when compared with the reference drugs Clotrimazole and Terbinafine. Molecular properties of the newly 
synthesized Schiff bases were performed by online software, and results showed good drug-like properties. The results showed new Schiff 
bases further optimized as a lead compound as anti-Candida potential. 
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1. INTRODUCTION 
Schiff bases are the key intermediates also as common 
ligands in the organic synthesis and have been shown to 
exhibit a broad range of biological activities, including 
antimicrobial, antiviral, antihelmintic, antiproliferative, and 
antioxidant1-8. The imine group present in such compounds 
has been shown to be essential for their biological activities. 
Clotrimazole and Terbinafine are the antifungal drugs 
containing nitrogen hetero atom into their structures. The 
ample evidence reported in the literature on the biological 
potential of Schiff bases containing C=N in their structure9-10 
led us to the synthesis, physico-chemical characterization 
and antifungal evaluation of new Schiff bases containing 
nitrogen hetro atom. The pharmacokinetic and 
pharmacodynamic behavior of molecules inside the human 
body is influenced by their molecular properties, molecular 
size, flexibility and the presence of different pharmacophore 
features. The in vivo experimental determination of 
pharmacokinetic parameters of newly synthesized 
compounds is uneconomical and time consuming. From this 
point of view, molecular properties can predict by the online 
software11. The molecular properties of the new compounds 
could help to eliminate the molecules likely to fail in the early 
stage of drug discovery. In view of these observations, we 
herein report the synthesis of new Schiff bases and 
evaluation as antifungal agents. 
2. MATERIAL AND METHODS 
Melting points of the synthesized compounds were 
determined by open capillary method and are uncorrected. 
The IR spectra of synthesized compounds were recorded in 
potassium bromide discs on Schimadzu FTIR 
Spectrophotometer 8300. The 1H-NMR spectra of the 
synthesized compounds were recorded in CDCl3 as solvent 
using AV-300 BROKE JEOL Spectrophotometer and 
tetramethylsilane (TMS) as an internal standard. All reagents 
were of commercial quality and were used without further 
purification. The reactions progress was monitored by thin-
layer chromatography (TLC) using silica gel G and spots 
were visualized with iodine. 
Experimental 
Synthesis of 2-phenoxy-1-phenylethanone (3) 
Equimolar amounts of 2-bromo-1-phenylethanone 1 
(0.01mol), phenol 2 (0.01 mol) and K2CO3 (0.02 mol) in dry 
acetonitrile was refluxed for about 6 h. The mixture was 
filtered and solvent was removed under reduced pressure. 
The resulting solid was washed with excess of water. The 
crude product was purified by recrystallization from ethanol 
to afford compound 3. Yield: 75.0 %, mp: 62-64oC, Rf: 0.69 
(n-Hexane: Ethyl acetate; 3:1). 
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General procedure for the synthesis of Schiff bases: N-(2-
phenoxy-1-phenylethylidene) substituted aniline (SA1-- 
SA16) 
A mixture of compound 3 (0.01 mol), substituted aniline 4 
(0.01mol) and 1 ml of glacial acetic acid in ethanol was 
refluxed on water bath for 8 h. The mixture was allowed to 
cool, and then the separated solid was filtered and 
recrystallized from ethanol to afford the SA1-16. 
 
 
 
Scheme 1: Synthesis of Schiff bases (SA1-16). 
 
Molecular property prediction of Schiff bases (SA1-16).  
A set of molecular properties molar refractivity, topological 
surface area and log P were computed for the target 
compounds as well as two standard drugs Clotrimazole and 
Terbinafine using Chem 3D Ultra version 12.0, software 
programs. The observations are depicted in Tables1.  
 
Table 1: Molecular property prediction of the Schiff bases (SA1-SA16). 
Cpd. Code. R MWa MRb tPSAc Log P 
SA1 -H 287.36 89.95 21.59 4.95 
SA2 4-CH3 301.38 95.48 21.59 5.43 
SA3 4-Cl 321.80 94.19 21.59 5.51 
SA4 4-Br 366.25 97.28 21.59 5.78 
SA5 3,4-Cl 356.25 98.80 21.59 6.06 
SA6 2-NO2 332.35 NC 73.40 4.34 
SA7 3-Cl 321.80 94.19 21.59 5.51 
SA8 4-NO2 332.35 NC 73.40 4.34 
SA9 4-OCH3 317.38 96.84 30.82 4.82 
SA10 2-Cl 321.80 94.19 21.59 5.51 
SA11 2-Cl, 4-NO2 366.80 NC 73.40 4.96 
SA12 3-NO2 332.35 NC 73.40 4.34 
SA13 2-Br 366.25 97.28 21.59 5.78 
SA14 4-F 305.35 89.99 21.59 5.11 
SA15 2-OCH3 317.38 96.84 30.82 4.82 
SA16 2-CH3 301.38 95.48 21.59 5.43 
Clotrimazole  344.82 102.07 15.6 5.19 
Terbinafine  291.43 99.36 3.24 5.52 
Abbreviations: a Molecular weight, bMolar refractivity, cTopological polar surface area; NC: Not calculated. 
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Antimicrobial Activity 
The antifungal testing was performed using the cup diffusion 
technique. The synthesized compounds, as 1 mg/ml 
solutions in dimethylformamide (DMF), were evaluated in 
vitro for activity against C. albicans by the cup diffusion 
technique12. Compounds showing inhibitory zones of at least 
20 mm were considered active and were further evaluated 
for their minimal inhibitory concentration (MIC) using the 
two-fold serial dilution method13. Clotrimazole and 
Terbinafine were used as standard antifungal agents. 
Dimethylformamide was used as a control. Sterile nutrient 
agar was inoculated with the test organisms (each 100 mL of 
the medium received 1 mL of 24 h broth culture), and then 
seeded agar was poured into sterile petri dishes. Cups (8 
mm in diameter) were cut in the agar, and each cup received 
0.1 mL of the test compound solution. The plates were then 
incubated at 37oC for 24 h. The activities were estimated as 
zones of inhibition in mm diameter (Table 2). Clotrimazole 
and Terbinafine solutions (0.01%) were used as reference 
standards. DMF did not show any inhibition zones. 
Minimum inhibitory concentration (MIC) measurement 
Using the two-fold serial dilution method, the test organisms 
were grown in suitable broth for 48 h for fungi at 37oC. Two-
fold serial dilutions of the test compounds solutions were 
prepared using the suitable broth to obtain concentrations 
between 1000 and 15.62 μg/mL. The tubes were then 
inoculated with the test organism (each 5 mL received 0.1 
mL of the above inoculum) and were incubated at 37oC for 
48 hr. The tubes were then observed for the presence or 
absence of microbial growth. The lowest concentration 
showing no growth was taken as the minimum inhibitory 
concentration. The MIC values of the prepared compounds 
are listed in Table 2. 
3. RESULTS AND DISCUSSION 
The target compounds SA1-16 were prepared as outlined in 
Scheme 1.The 2-bromo-1-phenylethanone 1 (0.01mol), 
phenol 2 (0.01 mol) and K2CO3 (0.02 mol) in dry acetonitrile 
was refluxed for about 6 h. The mixture was filtered and 
solvent was removed under reduced pressure. The obtained 
product was purified by recrystallization from ethanol to 
afford compound 3. The Schiff bases SA1-16 were prepared 
by refluxed of compound 3 with different aromatic anilines 4 
in ethanol. The purity of the compounds was monitored by 
TLC and the structure of the compounds was deduced on the 
basis of spectral data. The molecular property prediction 
was done for the target compounds. All Schiff base have 
molar refractivity under 130. The topological polar surface 
area (tPSA) is a measure of a molecule’s hydrogen bonding 
capacity and its value should not exceed certain limit. 
Topological polar surface area (tPSA) values for the test 
compounds were well within these limits (21.59-73.40). The 
log P values of test compounds were (4.34-6.06) within the 
range of standard drugs which shows that these compounds 
have a potential to effectively cross the blood brain barrier. 
The synthesized compounds were tested for activity against 
C. albicans. The results of antifungal activity are shown in 
table 2. It is evident from the results of the Schiff bases 
containing halogen atom like chloro, bromo and fluro at 
postion-4 (SA3, SA4 and SA14) were showing most potent 
antifungal activity as compared to the other Schiff bases. It is 
highlighting the importance of presence of electron 
withdrawing groups in the phenyl ring. The other Schiff 
bases (SA1, SA7-9, SA-14 and SA15) showed the variations 
in the antifungal activity. The ortho substituted (SA6, SA10, 
SA13 and SA16 except SA15) were the inactive antifungal 
agents in the series of Schiff’s bases. Among the compound 
SA3 was showed most potent antifungal activity in the 
synthesized compounds.  
 
Table 2: The Antifungal Activity of Schiff bases (SA1-16). 
Compound Code Zone of Inhibition  
(in mm) Against C. Albicans 
MIC (µg/ml) Against C. 
Albicans 
SA-1             20 93.72 
SA-2             14 >125.96 
SA-3              24 15.62 
SA-4 22 15.62 
SA-5 16 >125.96 
SA-6 16 >125.96 
SA-7 20 125.96 
SA-8 20 62.48 
SA-9 20 62.48 
SA-10 16 >125.96 
SA-11 16 >125.96 
SA-12 16 >125.96 
SA-13 16 >125.96 
SA-14 22 31.24 
SA-15 20 125.96 
SA-16 18 >125.96 
Clotrimazole 26 1.95 
Terbinafine 26 2.60 
The compounds having zone of inhibition 20 mm or greater than 20 mm is considered as active. 
 
4. CONCLUSION 
The present study describes the synthesis and evaluation of 
antifungal activity of a series of Schiff bases. The synthesized 
compounds therefore, present a new scaffold that can be 
used to as lead in development of novel antifungal agents. 
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